Cardiovascular and

Join our bold mission of care

We live in a time where cardiopulmonary disease is a leading global health challenge with more than 35 million people losing their lives to it over the past few years. With an impressive 60-year legacy of cardiovascular innovation, our hearts and minds are focused on solving the greatest remaining unmet needs for patients and pursuing cures and therapies for those who need them most. It’s a career with the most heartfelt mission—won't you join us?

Cardiovascular leaders who are making a real difference

Dr. Dean Y. Li
Dean Y. Li, cardiologist and president of Merck Research Laboratories (MRL), discusses the state of fighting cardiovascular disease and our efforts that will push us to new heights to help patients improve their quality of cardiovascular and respiratory health.

“We've created a broad, promising pipeline to build on our legacy, and are deploying our unique expertise to advance innovations to people who need them.”

Opportunity to improve lives through breakthrough medicine

As science continues to advance, there are new opportunities to address the unmet needs of patients battling diseases like heart failure, PAH, thrombosis, and atherosclerosis. Are you passionate about helping people improve their cardio and respiratory health? This could be a great career opportunity for you to help improve patients’ lives on a large scale.

Growth into the next decade

We work with experts across the cardiovascular community to advance research that can help improve the lives of patients with cardiovascular risk. We’ll continue to build on our history of innovative cardiovascular & respiratory disease therapies to increase our understanding and help patients around the world. Here’s what we’re doing to help fight the cardiovascular & respiratory disease epidemic:
Recent growth
2021 growth in our broad, late-stage cardiovascular pipeline. With many internal advancements and vigorous business development, exceptional career opportunities may be ahead.
Promising future
Anticipated mid-2030 revenue generated by our cardiovascular and pulmonary portfolio.
Ongoing investment
Number of dedicated colleagues in our state-of-the-art facility near South San Francisco—just one example of our continuing investment in cardiovascular drug discovery.

Making a heartfelt difference

Join our efforts toward cardiovascular and respiratory success.
Merck Research Labs, employee at work

Our R&D efforts

We’re determined to build upon our fundamental research strengths to deliver innovation to patients and physicians worldwide, expand our legacy of invention every day, and provide biomedical leadership in pharmaceutical R&D to address unmet needs and the best external science. Our therapeutic areas of focus are defined by our strongest scientific discoveries and our dedication to advance the most promising product opportunities.

Our commercial efforts

Our commercial organization is driven by the impact they can make in offering hope to patients. Our teams in sales, marketing, market access, and business development work tirelessly to convert innovative science into deliverable offerings that support patients, payers, and physician’s needs. We take a customer-centric approach leveraging emerging digital technologies and data analysis to better understand our patients needs and to improve patients’ access to our medicines.
Human Health rep meeting with cardiologist
Research Lab employees in meeting of office

How we’re making the most difference

Our biggest, most effective differentiator: the strong, cohesive bond between our R&D and commercial teams that allows us to continue to fight the cardiovascular disease epidemic with everything we’ve got. Join a collaborative and innovative team of Cardiovascular & Respiratory Research & Development (MRL) and Human Health (HH) professionals in truly transformational medical science.

Voices of cardiovascular & respiratory success

What I have enjoyed most since transitioning from academic medicine to Merck is working together in cross functional teams to collaborate on the strategy and execution of clinical development plans for exciting new drugs in the cardiovascular pipeline.

G. Brandon Atkins
Dist. Scientist, Clinical Research, GCD Cardiovascular & Respiratory

Merck aims to improve the lives of patients with cardiovascular and respiratory diseases through meaningful investment in creating leaders in cardiovascular and respiratory drug development.

Portrait of Paul Reyfman
Paul Reyfman
Principal Scientist, Clinical Research, GCD Cardiovascular & Respiratory

I’m humbled to be part of a team inspired and driven by the singular purpose to uncover, develop and deliver breakthroughs for patients as quickly and safely as possible.

Portrait of Paul Reyfman
Adam Castaño
MD, MS, Senior Medical Director, Global Clinical Development, Cardiovascular Disease

I joined our team to impact patient care at a larger scale, but I still carry my patients' stories with me.

Portrait of Dr. Joerg Koglin
Joerg Koglin
VP, Therapeutic Area Head, Global Clinical Development, Cardiovascular

Lorem Ipsum

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum

Connect with us on social

Beware of hiring scams. Review our Applicant Notice.

This careers website is intended for Residents of the United States, Canada & Puerto Rico. Residents in other markets, please visit our MSD Careers page. Information on this site is for the purpose of presenting career opportunities at our organization and give our audience a view of our culture, diversity and growth opportunities. Our Company is an equal opportunity employer, Minority/Female/Disability/Veteran, proudly embracing diversity in all of its manifestations.